Cargando…
Glutathione S-conjugates as prodrugs to target drug-resistant tumors
Living organisms are continuously exposed to xenobiotics. The major phase of enzymatic detoxification in many species is the conjugation of activated xenobiotics to reduced glutathione (GSH) catalyzed by the glutathione-S-transferase (GST). It has been reported that some compounds, once transformed...
Autores principales: | Ramsay, Emma E., Dilda, Pierre J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127970/ https://www.ncbi.nlm.nih.gov/pubmed/25157234 http://dx.doi.org/10.3389/fphar.2014.00181 |
Ejemplares similares
-
A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin
por: Li, Zuojun, et al.
Publicado: (2018) -
Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs
por: Deng, Chaoyi, et al.
Publicado: (2022) -
From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022) -
An Orally Bioavailable (Mice) Prodrug of Glutathione
por: Crankshaw, Daune L., et al.
Publicado: (2021) -
Metabolism and Bioactivation of Corynoline With Characterization of the Glutathione/Cysteine Conjugate and Evaluation of Its Hepatotoxicity in Mice
por: Liu, Ruijuan, et al.
Publicado: (2018)